Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Batlle

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Kidney International|December 9, 2016
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathyJan Wysocki, Minghao Ye, Ahmed M Khattab, et al.
Journal of the American Society of Nephrology : JASN|February 2, 2021
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney OrganoidsJan Wysocki, Minghao Ye, Luise Hassler, et al.
Kidney International|April 6, 2012
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in miceRenisha Nadarajah, Rosangela Milagres, Marc Dilauro, et al.
Hypertension (Dallas, Tex. : 1979)|July 11, 2012
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2Minghao Ye, Jan Wysocki, Francisco R Gonzalez-Pacheco, et al.
Advances in Chronic Kidney Disease|October 20, 2004
Effect of predialysis eating on measurement of urea reduction ratio and Kt/VNaveen Singri, Duncan Johnstone, James Paparello, et al.
Kidney360|April 16, 2024
Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized StudyStephen R Ash, Daniel Batlle, Jessica Kendrick, et al.
Plos One|January 9, 2014
Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouseMarta Riera, Eva Márquez, Sergi Clotet, et al.
Kidney International Reports|December 12, 2022
Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin TherapyJessica Navarro, Alejandro Sanchez, Sheeba H Ba Aqeel, et al.
Kidney International|April 26, 2018
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activationPan Liu, Jan Wysocki, Tomokazu Souma, et al.
Cells|February 9, 2024
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta VariantCosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Kidney International|December 9, 2016
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathyJan Wysocki, Minghao Ye, Ahmed M Khattab, et al.
Journal of the American Society of Nephrology : JASN|February 2, 2021
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney OrganoidsJan Wysocki, Minghao Ye, Luise Hassler, et al.
Kidney International|April 6, 2012
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in miceRenisha Nadarajah, Rosangela Milagres, Marc Dilauro, et al.
Hypertension (Dallas, Tex. : 1979)|July 11, 2012
Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2Minghao Ye, Jan Wysocki, Francisco R Gonzalez-Pacheco, et al.
Advances in Chronic Kidney Disease|October 20, 2004
Effect of predialysis eating on measurement of urea reduction ratio and Kt/VNaveen Singri, Duncan Johnstone, James Paparello, et al.
Kidney360|April 16, 2024
Sodium Zirconium Cyclosilicate in CKD, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized StudyStephen R Ash, Daniel Batlle, Jessica Kendrick, et al.
Plos One|January 9, 2014
Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouseMarta Riera, Eva Márquez, Sergi Clotet, et al.
Kidney International Reports|December 12, 2022
Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin TherapyJessica Navarro, Alejandro Sanchez, Sheeba H Ba Aqeel, et al.
Kidney International|April 26, 2018
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activationPan Liu, Jan Wysocki, Tomokazu Souma, et al.
Cells|February 9, 2024
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta VariantCosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.
Pageof 16